The current method of treating diabetic foot is associated with a high risk of serious amputations and mortality.
Recently, several systems have been developed capable of releasing antibiotics at a local level, thereby reducing the risk of postoperative infections and thus accelerating healing processes.
The present analysis was retrospectively performed on a consecutive series of patients with diabetes and forefoot DFO who underwent minor amputation (i.e. toe amputation, metatarsal-phalangeal osteoarthrotomy and/or metatarsal osteotomy) using local antibiotics in calcium-sulphate granules (Stimulan®, Biocomposites Ltd, UK) at the Diabetic Foot Unit of Careggi Hospital, Florence, Italy, between 1 June 2021 and 1 June 2022.
HERE is a link to our webside about Stimulan®.
Journal of Wound Management 2023;24(2):19-25.
Benedetta Ragghianti1, Alberto Piaggesi2, Edoardo Mannucci1, Matteo Monami*1
1Diabetology, Careggi Hospital and University of Florence, Florence, Italy
2Diabetic Foot Section, Department of Medicine, University Hospital of Pisa, Italy1
